IN8bio Inc (INAB): Next-Year EPS Estimate 26.02%
As of 2026-05-10, IN8bio Inc (INAB) has a next-year EPS growth estimate of 26.02%.
On 2026-05-10, analyst consensus for INAB's next-year EPS growth shifted from 25.37% to 26.02% — a positive change of 0.65 percentage points. Current-year growth is projected at 58.45%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 26.02%
- EPS growth this year
- 58.45%
- EPS next quarter (est)
- -$0.49
- Last price
- $1.58
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-10 | 26.02% | 58.45% | -$0.49 | $1.58 |
| 2026-05-07 | 25.37% | 43.77% | -$0.62 | $1.60 |
| 2026-05-06 | 25.37% | 43.77% | -$0.62 | $1.58 |
| 2026-05-05 | 25.37% | 43.77% | -$0.62 | $1.62 |
| 2026-05-04 | 25.37% | 43.77% | -$0.62 | $1.61 |
| 2026-05-03 | 25.37% | 43.77% | -$0.62 | $1.50 |
| 2026-04-30 | 27.87% | 52.93% | -$0.54 | $1.47 |
| 2026-04-29 | 27.87% | 52.93% | -$0.54 | $1.51 |
| 2026-04-28 | 27.87% | 52.93% | -$0.54 | $1.53 |
| 2026-04-27 | 27.87% | 52.93% | -$0.54 | $1.56 |
| 2026-04-26 | 27.87% | 52.93% | -$0.54 | $1.50 |
| 2026-04-24 | 27.87% | 52.93% | -$0.54 | $1.50 |
| 2026-04-23 | 27.87% | 52.93% | -$0.54 | $1.42 |
| 2026-04-22 | 27.87% | 52.93% | -$0.54 | $1.50 |
| 2026-04-21 | 27.87% | 52.93% | -$0.54 | $1.48 |
| 2026-04-20 | 27.87% | 52.93% | -$0.54 | $1.50 |
| 2026-04-19 | 27.87% | 52.93% | -$0.54 | $1.44 |
| 2026-04-16 | 27.87% | 52.93% | -$0.54 | $1.45 |
| 2026-04-15 | 27.87% | 52.93% | -$0.54 | $1.40 |
| 2026-04-14 | 27.87% | 52.93% | -$0.54 | $1.38 |
| 2026-04-13 | 27.87% | 52.93% | -$0.54 | $1.35 |
| 2026-04-12 | 27.87% | 52.93% | -$0.54 | $1.39 |
| 2026-04-10 | 27.87% | 52.93% | -$0.54 | $1.41 |
| 2026-04-09 | 27.87% | 52.93% | -$0.54 | $1.43 |
| 2026-04-08 | 27.87% | N/A | -$0.54 | $1.45 |
| 2026-04-07 | 27.87% | N/A | -$0.54 | $1.43 |
| 2026-04-06 | 27.87% | N/A | -$0.54 | $1.43 |
| 2026-04-05 | 27.87% | N/A | -$0.54 | $1.44 |
| 2026-04-03 | 27.87% | N/A | -$0.54 | $1.43 |
| 2026-04-02 | 27.87% | N/A | -$0.54 | $1.43 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is IN8bio Inc's next-year EPS growth estimate?▾
As of 2026-05-10, IN8bio Inc (INAB) has a next-year EPS growth estimate of 26.02%, based on analyst consensus.
When was the latest EPS estimate revision for INAB?▾
The most recent revision occurred on 2026-05-10, when analysts adjusted the next-year EPS growth estimate from 25.37% to 26.02%.
What sector and industry does IN8bio Inc belong to?▾
IN8bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INAB appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. IN8bio Inc (INAB) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports